The Greenlight To Exit Tech… And Pfizer’s Obesity Hopes 7/11/24
About this episode
Yields dropping to their lowest level in months, as this morning’s inflation report boosted hopes of a rate cut. So is the rate retreat the greenlight for investors to rotate into the laggards? Plus Pfizer’s getting in on the weight loss drug battle. How the pharma giant is moving forward with an obesity pill after encouraging data.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time CNBC's "Fast Money" publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from CNBC's "Fast Money"
Oracle Reports Results… And Mortgage Rates Top 7% 9/10/26
CNBC's "Fast Money"
Yields Surge, Stocks Fall… And Apple’s Foldable Phone 9/9/26
CNBC's "Fast Money"
Meta’s Latest AI Agent… And An AI-Powered Hedge Fund 9/8/26
CNBC's "Fast Money"
Markets look past strong jobs report... And tech’s next earnings test 9/4/26
CNBC's "Fast Money"